Back to
NORTHERN TRUST CORP
LCTX28 quarters
Position history for
NORTHERN TRUST CORP's holdings in LINEAGE CELL THERAPEUTICS IN
NORTHERN TRUST CORP holds 1.7M shares of LCTX (LINEAGE CELL THERAPEUTICS IN), worth $2.2M as of 2026-Q2. The position was increased (+231.9% shares). LCTX represents 0.0% of NORTHERN TRUST CORP's portfolio.
Current Value
$2.2M
Current Shares
1.7M
Total Value Change
+$993,213
Total Shares Change
+455,292
Quarter-by-Quarter History
Other major holders of LCTX: BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC